-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
At present, 25 provinces and cities have clarified the official implementation time of the fifth batch of national procurement:Xinjiang: September 15, 2021Tianjin: September 20, 2021Hunan: October 25, 2021Henan: October 1, 2021Tibet: October 1, 2021Hebei: October 1, 2021Chongqing: October 1, 2021Yunnan: October 8, 2021Guangdong: October 9, 2021Hainan: October 10, 2021Hubei: October 10, 2021Shandong: October 15, 2021Gansu: October 15, 2021Guizhou: October 15, 2021Jiangxi: October 18, 2021 Shaanxi: October 20, 2021 Liaoning: October 20, 2021 Shanxi: October 20, 2021 Fujian: October 20, 2021 Zhejiang: October 20, 2021 Heilongjiang: October 20, 2021 Shanghai: October 20, 2021 Qinghai: October 30, 2021 Sichuan: October 22, 2021 Jiangsu: 0:00 on October 31, 2021 As the dust settles on the fifth batch of national selection, all provinces and cities have successively issued documents to implement relevant work
.
On October 14th, Jiangsu Province issued the "Notice on Doing a Good Job in the Implementation of the Fifth Batch of Nationally Organized Drug Centralized Procurement Results", clarifying that the procurement price will be switched from the provincial platform at 24:00 on October 25; 24:00 on October 31 Start execution
.
Procurement cycle: implement the procurement cycle uniformly determined by the country
.
The purchase contract is signed once a year
.
The agreed procurement volume and procurement cycle for the first year are determined in accordance with the relevant rules in the "National Drug Centralized Procurement Document" (Guo Lian Cai Zi [2021] No.
2) issued by the National Joint Procurement Office
.
If the agreed purchase amount for the year is completed in advance during the purchase cycle, the selected companies will still supply the selected enterprises at the selected price until the expiration of the purchase cycle
.
The notice requires that the normalization and institutionalization of centralized drug procurement should be promoted.
All districts and cities should increase their political positions, strengthen organizational leadership, perform their duties, coordinate and cooperate, and actively promote the implementation of the fifth batch of national centralized drug procurement results.
Perform work
.
(1) Production capacity report to ensure supply
.
It is necessary to urge the selected companies to do a good job of predicting and preventing market risks, organize the production of drugs in accordance with the procurement contract, and report the production capacity, inventory, supply and production supply plan of the month through the provincial sunshine procurement platform before the 5th of each month to ensure that they are purchasing Meet the selected drug procurement needs of medical institutions in a timely manner within the cycle
.
The selected enterprises shall guarantee the supply in a timely manner for all medicines that are agreed to be purchased by medical institutions or whose excess quantities are within a reasonable range
.
(2) Balanced procurement and rational use of medicines
.
For drugs that are included in centralized procurement, the relevant medical institutions shall be guided to formulate a reasonable procurement and use plan based on the contracted procurement volume, and the procurement volume shall be distributed in a balanced manner.
The purchase shall not be concentrated; patients shall be guided to use the drugs rationally and the selected drugs shall be used first, but "One size fits all" measures such as single-purchasing selected drugs and forcing patients to change drugs shall not be adopted to ensure reasonable drug use and orderly supply
.
(3) Implement the advance payment and return the payment in time
.
It is necessary to continue to implement the medical insurance fund advance payment system, supervise the timely payment of funds by medical institutions, and help enterprises to speed up the return of funds, and further reduce the production costs of enterprises
.
(4) Strengthen publicity and follow-up monitoring
.
It is necessary to strengthen policy interpretation and positive publicity, strengthen public opinion monitoring, respond to social concerns in a timely manner, and create a good working atmosphere
.
It is necessary to strengthen the daily monitoring of the supply of selected drugs in the area under its jurisdiction, especially the supply and distribution of primary medical institutions.
If it cannot be supplied in time, it is necessary to understand the situation and analyze the reasons at the first time
.
Except for force majeure factors, the selected companies should strengthen the guarantee of supply, otherwise they will bear corresponding responsibilities and be regarded as breach of trust and breach of contract
.
Shanghai has also issued a clear document on "no one-size-fits-all measures should be taken
.
" On October 14, Shanghai issued a document to implement the fifth batch of national selection results, which will be implemented on October 20, 2021
.
It pointed out that it is necessary to take into account the stability of the supply of drugs and the stability of clinical medications, do not engage in centralized procurement of selected drugs, and do not adopt the “one size fits all” approach of drug withdrawal and drug withdrawal for unselected drugs.
In principle, the common name (including dosage form) of unselected drugs should be the same.
The proportion of equipment is maintained at about 20%
.
At present, 25 provinces and cities have clarified the official implementation time of the fifth batch of national procurement: Xinjiang: September 15, 2021 Tianjin: September 20, 2021 Hunan: October 25, 2021 Henan: October 1, 2021 Tibet: October 1, 2021 Hebei: October 1, 2021 Chongqing: October 1, 2021 Yunnan: October 8, 2021 Guangdong: October 9, 2021 Hainan: October 10, 2021 Hubei: October 10, 2021 Shandong: October 15, 2021 Gansu: October 15, 2021 Guizhou: October 15, 2021 Jiangxi: October 18, 2021 Shaanxi: October 20, 2021 Liaoning: October 20, 2021 Shanxi: October 20, 2021 Fujian: October 20, 2021 Zhejiang: October 20, 2021 Heilongjiang: October 20, 2021 Shanghai: October 20, 2021 Qinghai: October 30, 2021 Sichuan: October 22, 2021 Jiangsu: 0:00 on October 31, 2021 As the dust settles on the fifth batch of national selection, all provinces and cities have successively issued documents to implement relevant work
.
On October 14th, Jiangsu Province issued the "Notice on Doing a Good Job in the Implementation of the Fifth Batch of Nationally Organized Drug Centralized Procurement Results", clarifying that the procurement price will be switched from the provincial platform at 24:00 on October 25; 24:00 on October 31 Start execution
.
Procurement cycle: implement the procurement cycle uniformly determined by the country
.
The purchase contract is signed once a year
.
The agreed procurement volume and procurement cycle for the first year are determined in accordance with the relevant rules in the "National Drug Centralized Procurement Document" (Guo Lian Cai Zi [2021] No.
2) issued by the National Joint Procurement Office
.
If the agreed purchase amount for the year is completed in advance during the purchase cycle, the selected companies will still supply the selected enterprises at the selected price until the expiration of the purchase cycle
.
The notice requires that the normalization and institutionalization of centralized drug procurement should be promoted.
All districts and cities should increase their political positions, strengthen organizational leadership, perform their duties, coordinate and cooperate, and actively promote the implementation of the fifth batch of national centralized drug procurement results.
Perform work
.
(1) Production capacity report to ensure supply
.
It is necessary to urge the selected companies to do a good job of predicting and preventing market risks, organize the production of drugs in accordance with the procurement contract, and report the production capacity, inventory, supply and production supply plan of the month through the provincial sunshine procurement platform before the 5th of each month to ensure that they are purchasing Meet the selected drug procurement needs of medical institutions in a timely manner within the cycle
.
The selected enterprises shall guarantee the supply in a timely manner for all medicines that are agreed to be purchased by medical institutions or whose excess quantities are within a reasonable range
.
(2) Balanced procurement and rational use of medicines
.
For drugs that are included in centralized procurement, the relevant medical institutions shall be guided to formulate a reasonable procurement and use plan based on the contracted procurement volume, and the procurement volume shall be distributed in a balanced manner.
The purchase shall not be concentrated; patients shall be guided to use the drugs rationally and the selected drugs shall be used first, but "One size fits all" measures such as single-purchasing selected drugs and forcing patients to change drugs shall not be adopted to ensure reasonable drug use and orderly supply
.
(3) Implement the advance payment and return the payment in time
.
It is necessary to continue to implement the medical insurance fund advance payment system, supervise the timely payment of funds by medical institutions, and help enterprises to speed up the return of funds, and further reduce the production costs of enterprises
.
(4) Strengthen publicity and follow-up monitoring
.
It is necessary to strengthen policy interpretation and positive publicity, strengthen public opinion monitoring, respond to social concerns in a timely manner, and create a good working atmosphere
.
It is necessary to strengthen the daily monitoring of the supply of selected drugs in the area under its jurisdiction, especially the supply and distribution of primary medical institutions.
If it cannot be supplied in time, it is necessary to understand the situation and analyze the reasons at the first time
.
Except for force majeure factors, the selected companies should strengthen the guarantee of supply, otherwise they will bear corresponding responsibilities and be regarded as breach of trust and breach of contract
.
Shanghai has also issued a clear document on "no one-size-fits-all measures should be taken
.
" On October 14, Shanghai issued a document to implement the fifth batch of national selection results, which will be implemented on October 20, 2021
.
It pointed out that it is necessary to take into account the stability of the supply of drugs and the stability of clinical medications, do not engage in centralized procurement of selected drugs, and do not adopt the “one size fits all” approach of drug withdrawal and drug withdrawal for unselected drugs.
In principle, the common name (including dosage form) of unselected drugs should be the same.
The proportion of equipment is maintained at about 20%
.
At present, 25 provinces and cities have clarified the official implementation time of the fifth batch of national procurement: At present, 25 provinces and cities have clarified the official implementation time of the fifth batch of national procurement: Xinjiang: September 15, 2021 Tianjin: September 20, 2021 Hunan: October 25, 2021 Henan: October 1, 2021 Tibet: October 1, 2021 Hebei: October 1, 2021 Chongqing: October 1, 2021 Yunnan: October 8, 2021 Guangdong: October 9, 2021 Hainan: October 10, 2021 Hubei: October 10, 2021 Shandong: October 15, 2021 Gansu: October 15, 2021 Guizhou: October 15, 2021 Jiangxi: October 18, 2021 Shaanxi: October 20, 2021 Liaoning: October 20, 2021 Shanxi: October 20, 2021 Fujian: October 20, 2021 Zhejiang: October 20, 2021 Heilongjiang: October 20, 2021 Shanghai: October 20, 2021 Qinghai: October 30, 2021 Sichuan: October 22, 2021 Jiangsu: 0:00 on October 31, 2021 As the dust settles on the fifth batch of national selection, all provinces and cities have successively issued documents to implement relevant work
.
On October 14th, Jiangsu Province issued the "Notice on Doing a Good Job in the Implementation of the Fifth Batch of Nationally Organized Drug Centralized Procurement Results", clarifying that the procurement price will be switched from the provincial platform at 24:00 on October 25; 24:00 on October 31 Start execution
.
Procurement cycle: implement the procurement cycle uniformly determined by the country
.
The purchase contract is signed once a year
.
The agreed procurement volume and procurement cycle for the first year are determined in accordance with the relevant rules in the "National Drug Centralized Procurement Document" (Guo Lian Cai Zi [2021] No.
2) issued by the National Joint Procurement Office
.
If the agreed purchase amount for the year is completed in advance during the purchase cycle, the selected companies will still supply the selected enterprises at the selected price until the expiration of the purchase cycle
.
Business enterprise procurement procurement The notice requires that the normalization and institutionalization of centralized drug procurement should be promoted.
All districts and cities should increase their political positions, strengthen organizational leadership, perform their duties, coordinate and cooperate, and actively promote the implementation of the fifth batch of national centralized drug procurement results.
Perform work
.
(1) Production capacity report to ensure supply
.
It is necessary to urge the selected companies to do a good job of predicting and preventing market risks, organize the production of drugs in accordance with the procurement contract, and report the production capacity, inventory, supply and production supply plan of the month through the provincial sunshine procurement platform before the 5th of each month to ensure that they are purchasing Meet the selected drug procurement needs of medical institutions in a timely manner within the cycle
.
The selected enterprises shall guarantee the supply in a timely manner for all medicines that are agreed to be purchased by medical institutions or whose excess quantities are within a reasonable range
.
(2) Balanced procurement and rational use of medicines
.
For drugs that are included in centralized procurement, the relevant medical institutions shall be guided to formulate a reasonable procurement and use plan based on the contracted procurement volume, and the procurement volume shall be distributed in a balanced manner.
The purchase shall not be concentrated; patients shall be guided to use the drugs rationally and the selected drugs shall be used first, but "One size fits all" measures such as single-purchasing selected drugs and forcing patients to change drugs shall not be adopted to ensure reasonable drug use and orderly supply
.
(3) Implement the advance payment and return the payment in time
.
It is necessary to continue to implement the medical insurance fund advance payment system, supervise the timely payment of funds by medical institutions, and help enterprises to speed up the return of funds, and further reduce the production costs of enterprises
.
(4) Strengthen publicity and follow-up monitoring
.
It is necessary to strengthen policy interpretation and positive publicity, strengthen public opinion monitoring, respond to social concerns in a timely manner, and create a good working atmosphere
.
It is necessary to strengthen the daily monitoring of the supply of selected drugs in the area under its jurisdiction, especially the supply and distribution of primary medical institutions.
If it cannot be supplied in time, it is necessary to understand the situation and analyze the reasons at the first time
.
Except for force majeure factors, the selected companies should strengthen the guarantee of supply, otherwise they will bear corresponding responsibilities and be regarded as breach of trust and breach of contract
.
Shanghai has also issued a clear document on "no one-size-fits-all measures should be taken
.
" On October 14, Shanghai issued a document to implement the fifth batch of national selection results, which will be implemented on October 20, 2021
.
It pointed out that it is necessary to take into account the stability of the supply of drugs and the stability of clinical medications, do not engage in centralized procurement of selected drugs, and do not adopt the “one size fits all” approach of drug withdrawal and drug withdrawal for unselected drugs.
In principle, the common name (including dosage form) of unselected drugs should be the same.
The proportion of equipment is maintained at about 20%
.
Medicine medicine